Trial intelligence / Profile preview

Stinging Potential of Sunscreen Products

NCT02869113Completed

Sponsor
Bayer
Start
Jan 2015
Primary completion
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of BAY98751 in sunburn (3 arms), sponsored by Bayer. Primary endpoints: Subjective discomfort in the eye at 24 hours, Tearing/Lacrimation at 24 hours and 2 more. Started Jan 2015; status: completed.

02

Drugs

BAY98751
03

Conditions

sunburn

Beyond the preview

Go deeper on NCT02869113.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02869113.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call